Viewing Study NCT05636150


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2025-12-28 @ 5:40 AM
Study NCT ID: NCT05636150
Status: UNKNOWN
Last Update Posted: 2022-12-05
First Post: 2022-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module